Stifel Financial
IDYA icon

Stifel Financial’s IDEAYA Biosciences IDYA Stock Holding History

Stifel Financial’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$932K Sell
24,261
-356
-1% -$13.4K ﹤0.01% 2598
2026
Q2 		$917K Sell
24,617
-1,098
-4% -$33.6K ﹤0.01% 2611
2026
Q1 		$857K Sell
25,715
-1,624
-6% -$54.5K ﹤0.01% 2542
2025
Q4 		$945K Sell
27,339
-4,495
-14% -$143K ﹤0.01% 2471
2025
Q3 		$866K Buy
31,834
+1,312
+4% +$31.7K ﹤0.01% 2485
2025
Q2 		$642K Buy
30,522
+6,069
+25% +$116K ﹤0.01% 2614
2025
Q1 		$401K Buy
24,453
+751
+3% +$16K ﹤0.01% 2831
2024
Q4 		$609K Sell
23,702
-3,834
-14% -$109K ﹤0.01% 2562
2024
Q3 		$872K Sell
27,536
-1,888
-6% -$71.6K ﹤0.01% 2323
2024
Q2 		$1.03M Buy
29,424
+4,254
+17% +$168K ﹤0.01% 2142
2024
Q1 		$1.1M Buy
+25,170
New +$1.08M ﹤0.01% 2128

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Stifel Financial's IDYA Position: Q3 2026 in Review

Stifel Financial reduced its IDEAYA Biosciences (IDYA) stake by 1.4% in Q3 2026, selling an estimated $13.4K and leaving 24,261 shares worth $932K. The position accounts for ﹤0.01% of the portfolio, ranked #2598.

Stifel Financial first reported a position in IDYA in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.1M in Q1 2024. 204 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

  • Stifel Financial held 24,261 shares of IDEAYA Biosciences worth $932K as of Q3 2026.
  • Stifel Financial sold 356 IDEAYA Biosciences shares in Q3 2026, an estimated $13.4K.
  • IDEAYA Biosciences made up ﹤0.01% of Stifel Financial's portfolio in Q3 2026, its #2598 holding.
  • Stifel Financial first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 11 quarters since.
  • Stifel Financial's IDEAYA Biosciences position peaked at $1.1M in Q1 2024.
  • 204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Stifel Financial's 13F filing for Q3 2026, filed 12 Nov 2026.